Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Early cancer detection decision-support for primary care
London platform using validated clinical datapoints to flag likely cancer cases in primary care within around 60 seconds, founded by a practising GP.
The read
C the Signs analyses GP-entered patient data against validated clinical criteria to flag likely cancer cases in primary care and recommend the appropriate referral pathway within roughly 60 seconds, aiming to shorten the time between symptom presentation and specialist referral.
Founded by practising GP Dr Bea Bakshi, the company has run live studies with several NHS ICBs, including Somerset, and continues to raise from health-focused venture investors including Khosla Ventures and Google for Startups.
The Bridgehead view
A founder who is also a practising NHS GP gives C the Signs a credibility angle most AI-diagnostics vendors in this cohort can't claim, and its editorial story should lean on that clinical authenticity rather than compete on funding-round size alone against much better-capitalised peers.
Work with us
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
London clinical decision support company whose rules-based AI encodes cancer treatment pathways to help multidisciplinary teams triage patients to the right care faster.
ReadAI clinical decision support that scans GP electronic health records to flag patients who may have one of thousands of rare diseases, years earlier than standard care typically catches them.
ReadThe firm that knows medtech
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.